Adjuvant denosumab in early breast-cancer

Lancet Oncol. 2020 Mar;21(3):e123. doi: 10.1016/S1470-2045(20)30057-7.

Authors

Paul de Boissieu¹, Thierry Trenque²

Affiliations

¹ Epidemiology and Public Health Department, Kremlin-Bicêtre University Hospital, 94270 Le Kremlin-Bicêtre, France. Electronic address: [email protected].
² Pharmacovigilance and Pharmacoepidemiology Department, Reims University Hospital, Reims, France.

PMID: 32135107
DOI: 10.1016/S1470-2045(20)30057-7

No abstract available

Publication types

Letter
Comment

MeSH terms

Aromatase Inhibitors
Bone Density Conservation Agents*
Denosumab*

Substances

Aromatase Inhibitors
Bone Density Conservation Agents
Denosumab